Skip to main content
. Author manuscript; available in PMC: 2015 Oct 2.
Published in final edited form as: Curr Drug Targets. 2011 Aug;12(9):1235–1244. doi: 10.2174/138945011796150280

Table 3.

Patent publications related to FOXO1

Number Assignee name Brief description
US2008260700 Accili, Domenico; Kitamura, Tadahiro Established an immortalized pancreatic duct cell derived from a primary adult pancreatic duct epithelial cell culture, wherein the immortalized cell expresses wild type FoxO1 or mutated FoxO1; A method for treating beta cell failure with a subject spontaneously immortalized pancreatic ductal cell line expressing mutated FoxO1
US2008248995 Karnieli, Eddy; Armoni, Michal A method for detecting a modulator of transcription of a human PPAR gene promoter, wherein said FoxO1 protein binds directly and specifically through its DNA binding domain to a DNA region within the PPAR-gamma 2 promoter. A compound wherein the peptide is derived from the FoxO1 DNA-binding domain and some analog of said peptide.
EP1907016 Cho, Charles; Chanda, Sumit A method for identifying modulating compounds that affect FoxO1 localization.
US2008153767/WO2004031350 Dobie, Kenneth; Bhanot, Sanjay A series of antisense compounds, compositions are claimed for modulating the expression of FoxO1, a method for treatment of diseases associated with expression of FoxO1, in particular for treating diabetes